Browse All

Current Filters

CLEAR FILTER x

TITLE

Fixed Cycle and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT

Author:Gwathmey, Kelly   Bril, Vera   Habib, Ali A.   Claeys, Kristl G.   Hussain, Yessar   Sahagian, Gregory   Cortés-Vicente, Elena   Brauer, Edward   Guptill, Jeff   Gelinas, Deborah   Liu, Li   Jimenez, Rosa H.   Masschaele, Delphine   Mantegazza, Renato   Meisel, Andreas   Sun, Fang   Att,   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.004  

Author Institution:Austin Neuromuscular Center, Austin, TX  argenx, Ghent, Belgium  Charité – Universitätsmedizin Berlin, Berlin, Germany  

Phase 3 Trial Investigating Impact of Intravenous Efgartigimod in Anti-Acetylcholine Receptor Antibody Negative Generalized Myasthenia Gravis

Author:Howard Jr, James F.   Guptill, Jeff   Jimenez, Rosa H.   Gistelinck, Fien   Steeland, Sophie   

Session Name:P7: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.032  

Author Institution: